BD Diagnostics, a global leading technology company specializing in medical technology, and Belgium-based Diagenode SA, an international biopharmaceutical company, have launched kit of primers and probes respiratory FLU A/B Diagenode for use on the BD MAX in Europe. Kit primers and probes respiratory FLU A/B Diagenode got the CE and has been validated for use on the BD MAX with RNA extraction kit BD MAX RNA-3 reagent system opened, offering customers a fully automated system that standardizes the process of extraction and a friendly laboratory workflow and improved.
"As the first joint test validated for use on the BD MAX, launch kit respiratory FLU A/B Diagenode illustrates the flexibility and versatility of the BD MAX Open System and reagents to facilitate the rapid development molecular assay tests, "said Gregory Meehan , vice president of product planning at BD Diagnostics - Diagnostic Systems.
Through collaborations with developers of diagnostics in vitro (IVD) as leading Diagenode, Comics plans to expand its range of molecular biology tests by providing diagnostic tests in vitro for several clinically relevant syndromes. "The test FLU A/B Diagenode is the first in a series of tests that we plan to launch fully validated as products bearing the CE marking on the BD MAX. The uniqueness of the BD MAX system compared to other platforms is its ability to leverage the functionality of the instrument system open throughout the validation process, "said Didier Allaer CEO Diagenode.
The expanded menu of BD MAX System and its features open, full automation and standardized workflow will enable laboratories to consolidate and standardize a broad range of molecular tests to build programmes that meet both their clinical needs present and future.